Cemiplimab With Fianlimab for Resectable Non-Metastatic Colon Cancer

NCT07224022 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Colon Cancer

Interventions

DRUG: Cemiplimab + Fianlimab [Fixed Dose Combination (FDC)]

Sponsor

John Strickler, M.D.

Collaborators

[object Object]